Medic Debate

"The Israeli government has now confirmed that 50% of those fully vaccinated (2 shots) in the course of the last month have tested Covid positive. What this suggests is that Pfizer’s mRNA vaccine is not only conducive to deaths and injuries, it has resulted in an increase in Covid positive cases. 

Moreover, reports confirm that those vaccinated have contributed to the spread of the virus to those who have not received the mRNA vaccine. 

If you are pregnant, you can receive a COVID-19 vaccine. There is currently no evidence that any vaccines, including COVID-19 vaccines, cause fertility problems. However, data are limited about the safety of COVID-19 vaccines for people who are pregnant. CDC established the v-safe COVID-19 Vaccine Pregnancy Registry to learn more about this issue.

The registry is collecting health information from people who received COVID-19 vaccination in the periconception period (within 30 days before last menstrual period) or during pregnancy. The information is critical to helping people and their healthcare providers make informed decisions about COVID-19 vaccination. Participation is voluntary, and participants may opt out at any time.

The Indian Bar Association (IBA) sued WHO Chief Scientist Dr. Soumya Swaminathan on May 25, accusing her in a 71-point brief of causing the deaths of Indian citizens by misleading them about Ivermectin.

Point 56 states, “That your misleading tweet on May 10, 2021, against the use of Ivermectin had the effect of the State of Tamil Nadu withdrawing Ivermectin from the protocol on May 11, 2021, just a day after the Tamil Nadu government had indicated the same for the treatment of COVID-19 patients.”

If a trial in India finds WHO Chief Scientist Dr. Soumya Swaminathan guilty then the WHO Scientist could be sentenced to death or life in prisonIvermectin, used in Delhi beginning April 20, obliterated their COVID crisis. Cases dropped by 97% over 6 weeks. The fatal mistake would have been to NOT use Ivermectin. They used it and it saved Delhi. But tragically, Tamil Nadu did not, and their state was devastated. Their new cases rose from 10,986 to 36,184 – a tripling. Their refusal to use Ivermectin harmed them. Not only did Tamil Nadu’s cases rise to the highest in India, but their deaths skyrocketed from 48 on April 20 to 474 on May 27 – a rise of ten-fold.

Prof. Bhakdi is running a study looking at D-dimere concentrations before and a few days after the  jab. He and Wodarg are  now cohorting 50 doctors globally to study these blood parameters...His preliminary studies suggested that in over 30 % of the 60 patients studied by two medics, the blood coagulation and platelet clumping activity started ....that amounts to nearly 350 000 in a million. It is an iron rule in medicine, Bhakdi, said that it us standard medical knowledge that no substance is permitted to be administered, that causes blood clotting.

In response to the remarkable times we are living in, we have created this shareable, downloadable, interactive PDF Exploration document ( also found on-line HERE ), a gathering of our extensive research into the covid pandemic and its effects on us all. We hope that it will enable and inspire you to research further if you choose to.
We respect and appreciate that some of what you read and explore may challenge views you hold to be true at the moment, but we believe there are significant questions that need asking about the Covid19 narrative as it is. We all wish to make choices that will enable a full and healthy life for ourselves, our communities and our children, and that are right for now and for the future. THANK YOU"

Background: Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials. Areas of uncertainty: We assessed the efficacy of ivermectin treatment in reducing mortality, in secondary outcomes, and in chemoprophylaxis, among people with, or at high risk of, COVID-19 infection. Data sources: We searched bibliographic databases up to April 25, 2021. Two review authors sifted for studies, extracted data, and assessed risk of bias. Meta-analyses were conducted and certainty of the evidence was assessed using the GRADE approach and additionally in trial sequential analyses for mortality. Twenty-four randomized controlled trials involving 3406 participants met review inclusion. Therapeutic Advances: Meta-analysis of 15 trials found that ivermectin reduced risk of death compared with no ivermectin (average risk ratio 0.38, 95% confidence interval 0.19–0.73; n 5 2438; I2 5 49%; moderate-certainty evidence). This result was confirmed in a trial sequential analysis using the same DerSimonian–Laird method that underpinned the unadjusted analysis. This was also robust against a trial sequential analysis using the Biggerstaff–Tweedie method. Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% (95% confidence interval 79%–91%). Secondary outcomes provided less certain evidence. Low-certainty evidence suggested that there may be no benefit with ivermectin for “need for mechanical ventilation,

Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data from the study of SARS-CoV and other respiratory viruses suggest that anti-SARS-CoV-2 antibodies could exacerbate COVID-19 through antibody-dependent enhancement (ADE). Previous respiratory syncytial virus and dengue virus vaccine studies revealed human clinical safety risks related to ADE, resulting in failed vaccine trials. Here, we describe key ADE mechanisms and discuss mitigation strategies for SARS-CoV-2 vaccines and therapies in development. We also outline recently published data to evaluate the risks and opportunities for antibody-based protection against SARS-CoV-2